Pick n Pay puts the worst behind it

Loading player...
GUEST – Pick n Pay CEO Sean Summers
The Pick n Pay Group’s turnaround strategy is gaining traction with encouraging progress made across a number of key strategic and operational initiatives, including another formidable performance from its Boxer business and an underlying improvement in the performance of Pick n Pay supermarkets. These were key reflections in the Group’s interim results, published today, which also reported strong sales growth in Pick n Pay Clothing and Pick n Pay Online.
As anticipated, the first six months of FY25 (26 weeks ended 25 August 2024) remained challenging. However, due to improved store operations - showing a distinct turnaround - Pick n Pay CEO Sean Summers says they are quietly confident that they will reduce trading losses in the Pick n Pay segment by as much as 50% for the full-year.
Group turnover grew 3.7% to R56.1 billion, with like-for-like sales growth of 2.9%, with performance varying across divisions. Boxer recorded strong sales growth of 12.0%, well balanced between like-for-like sales (+7.7%) and sales from new stores (+4.3%). Boxer recorded another impressive earnings performance, with trading profit up 16% year-on-year. “The Boxer IPO remains pivotal to our strategy, and their remarkable performance continues to prove it is an exceptional business. We are excited to see it thrive as a listed entity,” said Summers. “It will be one of the most exciting listings on the JSE in years.”
28 Oct 2024 2PM English South Africa Business News · Investing

Other recent episodes

Why Women’s Financial Empowerment Is an Economic Multiplier

Women’s financial empowerment has the potential to drive economic growth, strengthen households and create lasting generational wealth. Kaya Biz speaks to Alexandra Nortier, Joint Head of Wealth Management at Investec Wealth & Investment International, about why Investec is backing the JSE SheInvests 2026 initiative, the barriers keeping women out of…
23 Jul 1PM 7 min

Affordable Diabetes Care Arrives in SA with Novo Nordisk

Novo Nordisk South Africa GM Sara Norcross explains the launch of the country’s only authorised copy of semaglutide, manufactured using the identical API, process and device as the originator — but at a more affordable price. We unpack what an authorised copy is, why SAHPRA registration matters, how the Acino…
23 Jul 1PM 14 min

SARB holds rates steady in July MPC – What It Means for You

Momentum economist Tshiamo Masike unpacks the SARB’s decision to pause, the upside inflation surprise, and the global factors driving the MPC’s decision. We explore how rising oil prices, geopolitical tensions, and weakening consumer confidence shaped the call — and what households, businesses and markets should expect next. A sharp, data‑driven…
23 Jul 1PM 14 min

PIC Board Exodus: Khaya Sithole on SA’s Biggest Asset Manager in Crisis

Six PIC directors have resigned, Treasury has begun steps to remove others, and whistleblower allegations of interference are mounting. Independent analyst Khaya Sithole breaks down the governance crisis unfolding at the Public Investment Corporation, what’s driving the board exodus, and what this means for the R2.5 trillion in assets the…
22 Jul 1PM 14 min

SA July MPC preview: Rates Outlook amid Hot Inflation

With inflation rising to 5.0%, fuel prices surging, and administered costs climbing, the SARB’s Monetary Policy Committee faces a tough call. Sanlam Investments economist Patrick Buthelezi unpacks today’s CPI print, the risks driving inflation, and what to expect from tomorrow’s MPC meeting. Essential listening for anyone watching interest rates and…
22 Jul 1PM 15 min